2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Vidac Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis 10% VDA-1102, 20% VDA-1102 - Actinic Keratosis | Phase 2 | Completed | Vidac Pharma | 83 | 2018-05-23 | 2022-08-23 |
| Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis Placebo, 5% VDA-1102, 10% VDA-1102 - Actinic Keratosis | Phase 2 | Completed | Vidac Pharma | 93 | 2016-07-15 | 2023-01-12 |
Keratosis, Actinic (2) · Carcinoma, Squamous Cell (1) · Precancerous Conditions (1)
Excipients (1)
United States (2)
Chaim M Brickman, MD (1) · Mark G Lebwohl, MD (1)